These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15791237)

  • 21. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
    J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells.
    Kajiya H; Ito M; Ohshima H; Kenmotsu S; Ries WL; Benjamin IJ; Reddy SV
    J Cell Biochem; 2006 Apr; 97(6):1362-9. PubMed ID: 16365894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells.
    Saunders MM; Taylor AF; Du C; Zhou Z; Pellegrini VD; Donahue HJ
    J Biomech; 2006; 39(8):1419-27. PubMed ID: 15953606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification.
    Al-Fakhri N; Hofbauer LC; Preissner KT; Franke FE; Schoppet M
    Thromb Haemost; 2005 Dec; 94(6):1335-7. PubMed ID: 16411417
    [No Abstract]   [Full Text] [Related]  

  • 25. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular clock mediates leptin-regulated bone formation.
    Fu L; Patel MS; Bradley A; Wagner EF; Karsenty G
    Cell; 2005 Sep; 122(5):803-15. PubMed ID: 16143109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.
    Blair JM; Zhou H; Seibel MJ; Dunstan CR
    Nat Clin Pract Oncol; 2006 Jan; 3(1):41-9. PubMed ID: 16407878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [BMP and osteoclastogenesis].
    Nakamura M; Udagawa N; Yamamoto Y; Nakamura H
    Clin Calcium; 2006 May; 16(5):809-15. PubMed ID: 16679623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption.
    Cozzani M; Giovannini I; Naccari R; Penolazzi L; Lambertini E; Borgatti M; Piva R; Gambari R; Siciliani G
    Prog Orthod; 2005; 6(2):238-47. PubMed ID: 16276433
    [No Abstract]   [Full Text] [Related]  

  • 30. Interplay between interferon and other cytokine systems in bone metabolism.
    Takayanagi H; Sato K; Takaoka A; Taniguchi T
    Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
    Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J
    J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
    Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
    J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Ann N Y Acad Sci; 2006 Apr; 1068():225-33. PubMed ID: 16831922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors.
    Huh YJ; Kim JM; Kim H; Song H; So H; Lee SY; Kwon SB; Kim HJ; Kim HH; Lee SH; Choi Y; Chung SC; Jeong DW; Min BM
    Cell Death Differ; 2006 Jul; 13(7):1138-46. PubMed ID: 16224490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
    Chang K; Chang WH; Huang S; Huang S; Shih C
    J Orthop Res; 2005 Nov; 23(6):1308-14. PubMed ID: 15913941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
    J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Melatonin and bone status].
    Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
    Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RANKL signaling in bone physiology and cancer.
    Dougall WC
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):317-22. PubMed ID: 18685382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
    Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J
    J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.